Psychopharmacology and Psychiatry Updates

A podcast by Psychopharmacology Institute

Categorie:

213 Episodio

  1. Complexities of OCD Treatment: Comorbidities and Other Considerations

    Pubblicato: 22/5/2023
  2. Lamotrigine and Lithium Combination Therapy for Rapid Cycling Bipolar Disorder

    Pubblicato: 17/5/2023
  3. Melatonin and Secretin for Youth

    Pubblicato: 12/5/2023
  4. Tackling NSSI in Adolescents: Can Medications Help?

    Pubblicato: 7/5/2023
  5. D-Cycloserine for Anxiety Disorders in Youth

    Pubblicato: 2/5/2023
  6. Clinical Significance of Antidepressants for the Treatment of Acute Depression

    Pubblicato: 27/4/2023
  7. Memantine: Potential Indications in Youth

    Pubblicato: 22/4/2023
  8. Low-Dose Olanzapine for Anorexia Nervosa

    Pubblicato: 17/4/2023
  9. Naltrexone in Youth: Exploring Potential Applications and Cautions

    Pubblicato: 12/4/2023
  10. Lamotrigine Titration: Slowing Down for Safer Treatment

    Pubblicato: 7/4/2023
  11. Using Benzodiazepines in Geriatric Patients

    Pubblicato: 2/4/2023
  12. Lithium Use in Pediatric Patients

    Pubblicato: 28/3/2023
  13. Using Mood Stabilizers in the Geriatric Population

    Pubblicato: 23/3/2023
  14. Bright Light Therapy for Perinatal Depression

    Pubblicato: 18/3/2023
  15. Using SSRIs in the Geriatric Population

    Pubblicato: 13/3/2023
  16. Safety and Efficacy of Duloxetine in Youth With MDD

    Pubblicato: 8/3/2023
  17. Challenges in Prescribing Psychotropics to the Geriatric Population

    Pubblicato: 3/3/2023
  18. Antidepressants and Vertebral and Hip Risk Fractures

    Pubblicato: 26/2/2023
  19. Antidepressants and Mood Stabilizers for Managing Explosive Behavior

    Pubblicato: 21/2/2023
  20. Risk of Substance Use Disorders in Children Treated With Psychotropics

    Pubblicato: 16/2/2023

5 / 11

Practical psychopharmacology updates for mental health clinicians. Useful for psychiatry / mental health professionals. Expert interviews and soundbites from CME presentations. Practical and free of commercial bias. Not sponsored by any pharmaceutical company.

Visit the podcast's native language site